methotrexate has been researched along with Endocrine System Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, P; Bhakta, N; Brinkman, TM; Chemaitilly, W; Cheung, YT; Ehrhardt, MJ; Green, DM; Huang, IC; Hudson, MM; Hyun, G; Krull, KR; Liu, W; Mulrooney, DA; Ness, KK; Robison, LL; Srivastava, D; Williams, AM | 1 |
Enya, M; Hirota, T; Horikawa, Y; Iizuka, K; Iwama, T; Kato, T; Kito, Y; Kuwabara-Ohmura, Y; Liu, Y; Miyazaki, T; Mizuno, M; Nonomura, K; Ohe, N; Saigo, C; Suwa, T; Takao, K; Tani, A; Yabe, D | 1 |
2 other study(ies) available for methotrexate and Endocrine System Diseases
Article | Year |
---|---|
Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood.
Topics: Adult; Antimetabolites, Antineoplastic; Cancer Survivors; Cardiovascular Diseases; Chronic Disease; Cognitive Dysfunction; Cranial Irradiation; Endocrine System Diseases; Humans; Injections, Spinal; Logistic Models; Mental Status and Dementia Tests; Methotrexate; Nervous System Diseases; Neurocognitive Disorders; Neurosurgical Procedures; Neurotoxicity Syndromes; Odds Ratio; Radiation Injuries; Respiratory Tract Diseases | 2021 |
Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report.
Topics: Adrenal Cortex Hormones; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Endocrine System Diseases; Hormone Replacement Therapy; Humans; Hypopituitarism; Hypothalamic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Treatment Outcome | 2021 |